1 – 39 of 39
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Real-world effectiveness of fremanezumab for the preventive treatment of migraine : Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
(
- Contribution to journal › Article
- 2020
-
Mark
Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system
(
- Contribution to journal › Article
-
Mark
Oxytocin as a regulatory neuropeptide in the trigeminovascular system : Localization, expression and function of oxytocin and oxytocin receptors
(
- Contribution to journal › Article
-
Mark
Vancouver Declaration II on Global Headache Patient Advocacy 2019
(
- Contribution to journal › Article
-
Mark
Cellular distribution of PACAP-38 and PACAP receptors in the rat brain : Relation to migraine activated regions
(
- Contribution to journal › Article
- 2019
-
Mark
Discovery of CGRP in relation to migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Distribution of CGRP and CGRP receptor components in the rat brain
(
- Contribution to journal › Article
-
Mark
PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater
(
- Contribution to journal › Article
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article
-
Mark
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
(
- Contribution to journal › Article
-
Mark
Dr James Lance, Professor of Neurology in Sydney, Australia, died on 20 February 2019, age 92
(
- Contribution to journal › Article
- 2018
-
Mark
Efficacy of strength training on tension-type headache : A randomised controlled study
(
- Contribution to journal › Article
-
Mark
The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial
(
- Contribution to journal › Article
- 2014
-
Mark
Reduced neck-shoulder muscle strength and aerobic power together with increased pericranial tenderness are associated with tension-type headache in girls: A case-control study.
(
- Contribution to journal › Article
- 2013
-
Mark
Pearls and pitfalls in neural CGRP immunohistochemistry
(
- Contribution to journal › Article
-
Mark
Role of VIP/PACAP in primary headaches.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Altered pain perception in children with chronic tension-type headache : is this a sign of central sensitisation?
(
- Contribution to journal › Article
- 2012
-
Mark
Prognosis of cerebral vein thrombosis presenting as isolated headache: Early vs. late diagnosis
(
- Contribution to journal › Article
-
Mark
Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method.
2012) In Cephalalgia(
- Contribution to journal › Article
- 2011
-
Mark
Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2.
(
- Contribution to journal › Article
-
Mark
Tracing neural connections to pain pathways with relevance to primary headaches.
(
- Contribution to journal › Article
- 2010
-
Mark
Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers
(
- Contribution to journal › Article
-
Mark
Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches
(
- Contribution to journal › Scientific review
-
Mark
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.
(
- Contribution to journal › Article
-
Mark
Segmental cerebral vasoconstriction: successful treatment of secondary cerebral ischaemia with intravenous prostacyclin.
(
- Contribution to journal › Article
- 2009
-
Mark
Brainstem and thalamic projections from a craniovascular sensory nervous center in the rostral cervical spinal dorsal horn of rats
(
- Contribution to journal › Published meeting abstract
-
Mark
CGRP and CGRP receptor distribution in the human trigeminal ganglion
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of the CGRP receptor antagonist telcagepant in human isolated coronary artery of different caliber
(
- Contribution to journal › Published meeting abstract
-
Mark
Characteriazation of the CGRP receptor antagonist telcagepant in human isolated cerebral and meningeal arteries
(
- Contribution to journal › Published meeting abstract
-
Mark
Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats.
(
- Contribution to journal › Article
- 2008
-
Mark
Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects.
(
- Contribution to journal › Article
-
Mark
The blood-brain barrier in migraine treatment.
(
- Contribution to journal › Article
- 2007
-
Mark
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Calcitonin gene-related peptide in cervicogenic headache
(
- Contribution to journal › Article
-
Mark
Correlation between CGRP and migraine attacks
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo
(
- Contribution to journal › Article
- 2004
-
Mark
Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.
(
- Contribution to journal › Scientific review
- 2002
-
Mark
Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2.
(
- Contribution to journal › Article
-
Mark
An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres
(
- Contribution to journal › Article